Defibrillator made by Turkish defense firm to help save lives in Africa

Defibrillator made by Turkish defense firm to help save lives in Africa

Aselsan to ink contracts with local partners in Africa for sale of its automatic external defibrillator device, says company head

By Goksel Yildirim

PRETORIA, South Africa (AA) - Turkish defense giant Aselsan's automatic external defibrillator (AED) device, will help save the lives of South African patients who suffer from sudden cardiac arrest, the head of the company said on Monday.

Aselsan, which started developing the device in 2018 with Metsis, a company that makes medical devices, has developed the AED last year under the Aselsan Heartline brand.

Having previously exported the device to France and Italy, Aselsan has since received orders from numerous other countries.

Speaking during the Africa Aerospace and Defence (AAD) fair in the capital Pretoria, Aselsan head Haluk Gorgun told Anadolu Agency that the firm would ink sales deals with local partners in Africa after the event.

"In particular, we will sell our defibrillator devices," he added, noting that Aselsan was showcasing its products in both the military and civilian fields during the event.

Underlining that the firm has had an office in South Africa since 2011 for its designing and production activities, Gorgun said the facility employed 47 expert staff in the electro-optical, electro-mechanic, and laser fields.

"With our presence here, I can already say that we can be more active and export more in the future with the negotiations and agreements we've made," he said.

"We have many opportunities in South Africa, where we can create solutions with our products not only in the field of defense but also in the civilian field."


*Writing and contributions by Gokhan Ergocun from Istanbul

Kaynak:Source of News

This news has been read 118 times in total

ADD A COMMENT to TO THE NEWS
UYARI: Küfür, hakaret, rencide edici cümleler veya imalar, inançlara saldırı içeren, imla kuralları ile yazılmamış,
Türkçe karakter kullanılmayan ve büyük harflerle yazılmış yorumlar onaylanmamaktadır.
Previous and Next News